Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06888024 · ClinicalTrials.gov registry record · NA

Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI

A NA study of May-Thurner Syndrome and Iliac Venous Compression, sponsored by Ningcheng Peter Li.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06888024 is a NA study of May-Thurner Syndrome and Iliac Venous Compression that is actively recruiting participants, run by Ningcheng Peter Li. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06888024, a NA study of May-Thurner Syndrome and Iliac Venous Compression, is actively recruiting participants, sponsored by Ningcheng Peter Li.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow characteristics of the iliac veins in patients with no imaging evidence of iliac venous disease. Arm 2: To assess the flow characteristics of the iliac veins in patients with left iliac vein compression syndrome (a.k.a. May-Thurner syndrome). Arm 3: To assess the flow characteristics of the iliac veins in patients status post iliac stent placement.

Interventions

  • PROCEDURE non-contrast enhanced abdomen and pelvis MRI

Study Locations (1)

Massachusetts

  • University of Massachusetts - Worcester

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-04-01
Est. Completion 2027-01-01
Phase NA

Sponsor

Ningcheng Peter Li

1 total trials

What the Registry Record Tells You About NCT06888024

The ClinicalTrials.gov registry entry for NCT06888024 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ningcheng Peter Li, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with May-Thurner Syndrome appearing as the primary indexed condition, and to 1 intervention - of which non-contrast enhanced abdomen and pelvis MRI is the first listed.

NCT06888024 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06888024 about?

NCT06888024 is a clinical study titled "Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI". The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow character...

What is the current status of trial NCT06888024?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-04-01. Estimated completion is 2027-01-01.

What conditions does trial NCT06888024 study?

This clinical trial studies the following conditions: May-Thurner Syndrome, Iliac Venous Compression.

What interventions are being tested in trial NCT06888024?

The interventions under investigation include: non-contrast enhanced abdomen and pelvis MRI (PROCEDURE).

Who is sponsoring clinical trial NCT06888024?

This trial is sponsored by Ningcheng Peter Li, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06888024 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for May-Thurner Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.